1-4 of 4
Yuankai Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study

Yuankai Shi, Qiqing Cai, Yu Jiang, Gang Huang, Minghong Bi, Baocheng Wang, Yuhong Zhou, Guowen Wang, Hongyan Ying, Zhiwei Tao, Chunmei Shi, Qian Guo, Chao Gao
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (24): 6445–6452.
https://doi.org/10.1158/1078-0432.CCR-20-2819
Published: 15 December 2020
View article titled, Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study
Open the PDF for Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study in another window
Includes: Supplementary data
Journal Articles

Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study

Ligang Xing, Yueyin Pan, Yuankai Shi, Yongqian Shu, Jifeng Feng, Wei Li, Lejie Cao, Lifeng Wang, Wei Gu, Yong Song, Puyuan Xing, Yutao Liu, Wen Gao, Jiuwei Cui, Nana Hu, Rutian Li, Hua Bao, Yang Shao, Jinming Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6168–6175.
https://doi.org/10.1158/1078-0432.CCR-20-2081
Published: 01 December 2020
View article titled, Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Open the PDF for Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study in another window
Includes: Supplementary data
Journal Articles

Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses

Yuankai Shi, Xiaoqing Liu, Jiatao Lou, Xiaohong Han, Lijian Zhang, Qingtao Wang, Baolan Li, Mei Dong, Yinghong Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 6016–6022.
https://doi.org/10.1158/1078-0432.CCR-14-0174
Published: 30 November 2014
View article titled, Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses
Open the PDF for Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses in another window
Journal Articles

A Severe Combined Immunodeficient–hu In vivo Mouse Model of Human Primary Mantle Cell Lymphoma

Michael Wang, Liang Zhang, Xiaohong Han, Jing Yang, Jianfei Qian, Sungyoul Hong, Pei Lin, Yuankai Shi, Jorge Romaguera, Larry W. Kwak, Qing Yi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 2154–2160.
https://doi.org/10.1158/1078-0432.CCR-07-4409
Published: 01 April 2008
View article titled, A Severe Combined Immunodeficient–hu <em>In vivo</em> Mouse Model of Human Primary Mantle Cell Lymphoma
Open the PDF for A Severe Combined Immunodeficient–hu <em>In vivo</em> Mouse Model of Human Primary Mantle Cell Lymphoma in another window